Spinal Restoration (Austin, TX), a clinical stage biotechnology company focused on the treatment of discogenic chronic low back pain, closed a $5M Series C financing. Participants include Austin Ventures, Santé Ventures, MB Venture Partners and Comerica Bank.


Collective IP the Most Comprehensive and Accurate View of Global Innovation and Organization of the International Technology Transfer Office Ecosystem